Raymond Schinazi Joins Precision BioSciences Board of Directors

72

DURHAM, N.C.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/celltherapy?src=hash" target="_blank"gt;#celltherapylt;/agt;–Precision BioSciences (“Precision”), a genome editing company dedicated to improving life (DTIL) through its proprietary ARCUS genome editing platform, has appointed Raymond Schinazi, PhD, Hon DSc to its board of directors. Dr. Schinazi is the Frances Winship Walters Professor of Pediatrics and director of the Laboratory of Biochemical Pharmacology at Emory University. “The cutting-edge technology developed by the Precision BioSciences team provides new opportunit http://www.businesswire.com/news/home/20190314005256/en/Raymond-Schinazi-Joins-Precision%C2%A0BioSciences-Board-Directors/?feedref=JjAwJuNHiystnCoBq_hl-c_SXB-bY2T43rxUBWxEIvSqcp-o_pnudlUwsb5apQ1S4gUE65BTfjH3-pSuqdv0gW3cb3F4oTIgUqCPafFkgu61_izUl0FZkbDFZ7ZhSEmC